Cleared Traditional

aprevo® TLIF-C Articulating System (K241019) - FDA 510(k) Clearance

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K241019 · Carlsmed · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2024
Decision
85d
Days
Class 2
Risk

K241019 is an FDA 510(k) clearance for the aprevo® TLIF-C Articulating System. Classified as Intervertebral Fusion Device With Bone Graft, Lumbar within the MAX classification (a category for intervertebral fusion devices and spinal implants), Class II - Special Controls.

Submitted by Carlsmed (Carlsbad, US). The FDA issued a Cleared decision on July 9, 2024 after a review of 85 days - a notably fast clearance cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3080 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Carlsmed devices

Submission Details

510(k) Number K241019 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 15, 2024
Decision Date July 09, 2024
Days to Decision 85 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
37d faster than avg
Panel avg: 122d · This submission: 85d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MAX Intervertebral Fusion Device With Bone Graft, Lumbar
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3080
Definition Intended To Stabilize Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MAX Intervertebral Fusion Device With Bone Graft, Lumbar

All 464
Devices cleared under the same product code (MAX) and FDA review panel - the closest regulatory comparables to K241019.
Solar™ Lumbar Interbody Fusion System
K240326 · Degen Medical, Inc. · Jul 2024
sagAlign Lumbar Cage System (Various PNs)
K241413 · Acuity Surgical Devices, LLC · Jul 2024
SPIRA® Anterior Lumbar Spacers
K234077 · Camber Spine Technologies · Jul 2024
Reef TO/TA System
K240830 · Orthofix Medical, Inc. · Jun 2024
Shoreline ACS Interbody System
K241466 · SeaSpine Orthopedics Corporation · Jun 2024
PILLAR SA Ti Spacer System (82-XXX)
K240749 · Orthofix, Inc. · May 2024